State of the art and prospects in the structure, activity, and response characteristics of C⁃reaction protein

LI Zhengjun; DUAN Wenjie; ZHANG Di; ZHANG Peilei; PAN Zishu

doi:10.14188/j.1671-8852.2024.0835

您当前的位置：

首页 >

文章列表页 >

State of the art and prospects in the structure, activity, and response characteristics of C⁃reaction protein

更新时间：2026-11-05

- State of the art and prospects in the structure, activity, and response characteristics of C⁃reaction protein
- Medical Journal of Wuhan University Vol. 46, Issue 10, Pages: 1370-1373(2025)
- 作者机构：
  
  1.郑州方欣生物科技有限责任公司河南郑州 451100
  2.河南杰瑞生物科技研究院有限公司河南郑州 451163
  3.武汉大学生命科学学院湖北武汉 430072
- 作者简介：
- 基金信息：
- DOI：10.14188/j.1671-8852.2024.0835
  CLC： R446.1
- Received：31 October 2024，
  
  Published：25 October 2025
- 稿件说明：
移动端阅览
李正钧,段文杰,张迪等.C反应蛋白结构活性与应答特征研究现状与展望[J].武汉大学学报（医学版）,2025,46(10):1370-1373.

LI Zhengjun,DUAN Wenjie,ZHANG Di,et al.State of the art and prospects in the structure, activity, and response characteristics of C⁃reaction protein[J].Medical Journal of Wuhan University,2025,46(10):1370-1373.
李正钧,段文杰,张迪等.C反应蛋白结构活性与应答特征研究现状与展望[J].武汉大学学报（医学版）,2025,46(10):1370-1373. DOI： 10.14188/j.1671-8852.2024.0835.

LI Zhengjun,DUAN Wenjie,ZHANG Di,et al.State of the art and prospects in the structure, activity, and response characteristics of C⁃reaction protein[J].Medical Journal of Wuhan University,2025,46(10):1370-1373. DOI： 10.14188/j.1671-8852.2024.0835.

摘要

C反应蛋白（CRP）是一种主要由肝脏合成的多功能蛋白质，与炎症反应相关的组织损伤事件会引起CRP血液浓度迅速变化。作为机体病理生理反应的重要生物标志物，CRP水平变化与人体健康状况密切相关。血液CRP浓度测定已在疾病临床诊断中广泛应用。本文综述了CRP结构、活性及应答动力学特征，并讨论了高敏C反应蛋白及其在预测心血管疾病等发病风险及预后评估中的意义。

Abstract

C⁃reactive protein (CRP) is a multifunctional protein primarily synthesized by the liver

blood CRP levels change rapidly and significantly in response to tissue⁃damaging events associated with inflammation. As a biomarker of pathophysiological response

the CRP levels are closely related to human health status and have been widely utilized in clinical diagnosis of diseases. This review will primarily focus on our current understanding of the structure

activity of CRP

as well as the kinetics of its response. In addition

the characterization of high⁃sensitivity CRP (hs⁃CRP) and its clinical significance in predicting the risk of cardiovascular diseases and in prognostic assessment are discussed.

关键词

Keywords

references

TILLETT W S , FRANCIS T . Serological reactions in pneumonia with a non⁃protein somatic fraction of pneumococcus [J ] . J Exp Med , 1930 , 52 ( 4 ): 561 ⁃ 571 .

SUCAJTYS⁃SZULC E , DEBSKA⁃SLIZIEN A , RUTKOWSKI B , et al . Hepatocyte nuclear factors as possible C⁃reactive protein transcriptional inducer in the liver and white adipose tissue of rats with experimental chronic renal failure [J ] . Mol Cell Biochem , 2018 , 446 ( 1/2 ): 11 ⁃ 23 .

DONG Q , WRIGHT J R . Expression of C⁃reactive protein by alveolar macrophages [J ] . J Immunol , 1996 , 156 ( 12 ): 4815 ⁃ 4820 .

JABS W J , LÖGERING B A , GERKE P , et al . The kidney as a second site of human C⁃reactive protein formation in vivo [J ] . Eur J Immunol , 2003 , 33 ( 1 ): 152 ⁃ 161 .

ZHANG K , XIE K , ZHANG C , et al . C⁃reactive protein testing to reduce antibiotic prescribing for acute respiratory infections in adults: A systematic review and meta⁃analysis [J ] . J Thorac Dis , 2022 , 14 ( 1 ): 123 ⁃ 134 .

KHAREL S , OJHA R , PREETHIS⁃KUMAR V , et al . C⁃reactive protein levels in patients with amyotrophic lateral sclerosis: A systematic review [J ] . Brain Behav , 2022 , 12 ( 3 ): e2532 .

JIANG Y , NI K , FANG M , et al . The effects of serum hs⁃CRP on the incidence of lung cancer in male patients with pulmonary tuberculosis [J ] . Iran J Public Health , 2019 , 48 ( 7 ): 1265 ⁃ 1269 .

PATHAK A , AGRAWAL A . Evolution of C⁃ceactive protein [J ] . Front Immunol , 2019 , 10 : 943 .

EMSLEY J , WHITE H E , O'HARA B P , et al . Structure of pentameric human serum amyloid P component [J ] . Nature , 1994 , 367 ( 6461 ): 338 ⁃ 345 .

VOLANAKIS J E , KAPLAN M H . Specificity of C⁃reactive protein for choline phosphate residues of pneumococcal C⁃polysaccharide [J ] . Proc Soc Exp Biol Med , 1971 , 136 ( 2 ): 612 ⁃ 614 .

PEPYS M B . The Pentraxins 1975⁃2018: Serendipity, diagnostics and drugs [J ] . Front Immunol , 2018 , 9 : 2382 .

MOULIOU D S . C⁃reactive protein: Pathophysiology, diagnosis, false test results and a novel diagnostic algorithm for clinicians [J ] . Diseases , 2023 , 11 ( 4 ): 132 .

POTEMPA L A , MALDONADO B A , LAURENT P , et al . Antigenic, electrophoretic and binding alterations of human C⁃reactive protein modified selectively in the absence of calcium [J ] . Mol Immunol , 1983 , 20 ( 11 ): 1165 ⁃ 1175 .

GODA T , MIYAHARA Y . Specific binding of human C⁃reactive protein towards supported monolayers of binary and engineered phospholipids [J ] . Colloids Surf B Biointerfaces , 2018 , 161 : 662 ⁃ 669 .

GODA T , MIYAHAR Y . Engineered zwitterionic phosphorylcholine monolayers for elucidating multivalent binding kinetics of C⁃reactive protein [J ] . Acta Biomater , 2016 , 40 : 46 ⁃ 53 .

WILLIAMS R D , MORAN J A , FRYER A A , et al . Monomeric C⁃reactive protein in serum with markedly elevated CRP levels shares common calcium⁃dependent ligand binding properties with an in vitro dissociated form of C⁃reactive protein [J ] . Front Immunol , 2020 , 11 : 115 .

TRIAL J , POTEMPA L A , ENTMAN M L . The role of C⁃reactive protein in innate and acquired inflammation: New perspectives [J ] . Inflamm Cell Signal , 2016 , 3 ( 2 ): e1409

DU CLOS T W , Mold C . C⁃reactive protein: An activator of innate immunity and a modulator of adaptive immunity [J ] . Immunol Res , 2004 , 30 ( 3 ): 261 ⁃ 277 .

ANTONELLI M , KUSHNER I . It's time to redefine inflammation [J ] . FASEB J , 2017 , 31 ( 5 ): 1787 ⁃ 1791 .

ALNAAS A A , MOON C L , ALTON M , et al . Conformational changes in C⁃reactive protein affect binding to curved membranes in a lipid bilayer model of the apoptotic cell surface [J ] . J Phys Chem B , 2017 , 121 ( 12 ): 2631 ⁃ 2639 .

RAJAB I M , HART P C , POTEMPA L A . How C⁃reactive protein structural isoforms with distinctive bioactivities affect disease progression [J ] . Front Immunol , 2020 , 11 : 2126 .

JI S R , WU Y , ZHU L I , et al . Cell membranes and liposomes dissociate C⁃reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m) [J ] . FASEB J , 2007 , 21 ( 1 ): 284 ⁃ 294 .

WU Y , POTEMPA L A , EI KEBIR D , et al . C⁃reactive protein and inflammation: Conformational changes affect function [J ] . Biol Chem , 2015 , 396 ( 11 ): 1181 ⁃ 1197 .

OLSON M E , HORNICK M G , STEFANSKI A , et al . A biofunctional review of C⁃reactive protein (CRP) as a mediator of inflammatory and immune responses: Differentiating pentameric and modified CRP isoform effects [J ] . Front Immunol , 2023 , 14 : 1264383 .

EKLUND C M . Proinflammatory cytokines in CRP baseline regulation [J ] . Adv Clin Chem , 2009 , 48 : 111 ⁃ 136 .

WANG M Y , ZHANG C M , ZHOU H H , et al . Identification of a distal enhancer that determines the expression pattern of acute phase marker C⁃reactive protein [J ] . J Biol Chem , 2022 , 298 ( 8 ): 102160 .

MACINTYRE S S , KUSHNER I , SAMOLS D . Secretion of C⁃reactive protein becomes more efficient during the course of the acute phase response [J ] . J Biol Chem , 1985 , 260 ( 7 ): 4169 ⁃ 4173 .

VIGUSHIN D M , PEPYS M B , HAWKINS P N . Metabolic and scintigraphic studies of radioiodinated human C⁃reactive protein in health and disease [J ] . J Clin Invest , 1993 , 91 ( 4 ): 1351 ⁃ 1357 .

BRAIG D , NERO T L , KOCH H G , et al . Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites [J ] . Nat Commun , 2017 , 8 : 14188 .

MACINTYRE S S . Regulated export of a secretory protein from the ER of the hepatocyte: A specific binding site retaining C⁃reactive protein within the ER is downregulated during the acute phase response [J ] . J Cell Biol , 1992 , 118 ( 2 ): 253 ⁃ 265 .

MACINTYRE S S , SCHULTZ D , KUSHNER I . Biosynthesis of C⁃reactive protein [J ] . Ann N Y Acad Sci , 1982 , 389 : 76 ⁃ 87 .

COLLEY C M , FLECK A , GOODE A W , et al . Early time course of the acute phase protein response in man [J ] . J Clin Pathol , 1983 , 36 ( 2 ): 203 ⁃ 207 .

BURGER V M , NOLASCO D O , STULTZ C M . Expanding the range of protein function at the far end of the order⁃structure continuum [J ] . J Biol Chem , 2016 , 291 ( 13 ): 6706 ⁃ 6713 .

LV J M , CHEN J Y , LIU Z P , et al . Celluar folding determinants and conformational plasticity of native C⁃reactive protein [J ] . Front Immunol , 2020 , 11 : 583 .

CHEN L , DENG H , CUI H , et al . Inflammatory responses and inflammation⁃associated diseases in organs [J ] . Oncotarget , 2018 , 9 ( 6 ): 7204 ⁃ 7218 .

PAPANICOLAOU D A , WILDER R L , MANOLAGAS S C , et al . The pathophysiologic roles of interleukin⁃6 in human disease [J ] . Ann Intern Med , 1998 , 128 ( 2 ): 127 ⁃ 137 .

ROST N S , WOLF P A , KASE C S , et al . Plasma concentration of C⁃reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study [J ] . Stroke , 2001 , 32 ( 11 ): 2575 ⁃ 2579 .

RIDKER P M , RIFAI N , ROSE L , et al . Comparison of C⁃reactive protein and low⁃density lipoprotein cholesterol levels in the prediction of first cardiovascular events [J ] . N Engl J Med , 2002 , 347 ( 20 ): 1557 ⁃ 1565 .

MCCORMACK J P , ALLAN G M . Measuring hsCRP⁃an important part of a comprehensive risk profile or a clinically redundant practice? [J ] . PLoS Med , 2010 , 7 ( 2 ): e1000196 .

TANG Y , FUNG E , XU A , et al . C⁃reactive protein and ageing [J ] . Clin Exp Pharmacol Physiol , 2017 , 44 Suppl 1 : 9 ⁃ 14 .

YOUSUF O , MOHANTY B D , MARTIN S S , et al . High⁃sensitivity C⁃reactive protein and cardiovascular disease: A resolute belief or an elusive link? [J ] . J Am Coll Cardiol , 2013 , 62 ( 5 ): 397 ⁃ 408 .

HEIKKILA K , EBRAHIM K S , LOWLOR D A . A systematic review of the association between circulating concentrations of C reactive protein and cancer [J ] . J Epidemiol Community Health , 2007 , 61 ( 9 ): 824 ⁃ 833 .

LI Y , ZHONG X , CHENG G , et al . Hs⁃CRP and all⁃cause, cardiovascular, and cancer mortality risk: A meta⁃analysis [J ] . Atherosclerosis , 2017 , 259 : 75 ⁃ 82 .

JIALAL I , DEVARAJ S , VENUGOPAL S K . C⁃reactive protein: Risk marker or mediator in atherothrombosis? [J ] . Hypertension , 2004 , 44 ( 1 ): 6 ⁃ 11 .

CARRERO J J , FRANKO M A , OBERGFELL A , et al . hsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: A healthcare⁃based study [J ] . J Am Heart Assoc , 2019 , 8 ( 11 ): e012638 .

RAGY M M , KAMAL N N . Linking senile dementia to type 2 diabetes: Role of oxidative stress markers, C⁃reactive protein and tumor necrosis factor⁃alpha [J ] . Neurol Res , 2017 , 39 ( 7 ): 587 ⁃ 595 .

UMEMURA A , OEDA T , YAMAMOTO K , et al . Baseline plasma C⁃reactive protein concentrations and motor prognosis in parkinson disease [J ] . PLoS One , 2015 , 10 ( 8 ): e0136722 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Correlation between ADAMTS13 and Kawasaki disease

Bioinformatic analysis of prognostic value and immune function of AHCY in pancreatic cancer

Role of microRNAs in the pathogenesis and therapy of post⁃traumatic stress disorder

Identification and validation of crucial genes in experimental autoimmune myocarditis using bioinformatics analysis

Comparative clinical efficacy of different acid formulations in the treatment of scalp seborrheic dermatitis

Related Author

HE Bing

LI Lingzhi

HUANG Tingting

XU Xiang

YANG Shutong

LI Xiaoou

LU Zhenpeng

WAN Hong

Related Institution

Department of Pediatrics, Renmin Hospital of Wuhan University

Department of Thoracic Surgery, Renmin Hospital of Wuhan University

Department of General Practice, Huanggang Central Hospital

Dept. of Applied Psychology， South⁃Central Minzu University

Dept. of Neuropsychology， Zhongnan Hospital of Wuhan University

AI问答

⁰